mozavaptan has been researched along with dinoprostone in 3 studies
| Studies (mozavaptan) | Trials (mozavaptan) | Recent Studies (post-2010) (mozavaptan) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 165 | 8 | 24 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | mozavaptan (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, K | 1 |
| Abe, K; Abe, T; Obinata, M; Takahashi, N; Takeuchi, K; Tsutsumi, E; Yanai, N | 1 |
| Chau, T; Inoue, T; Kawai, B; Koizumi, F; Kunihiro, N; Matsuo, A; Ohnishi, A; Okada, K; Tada, Y; Tanaka, T; Yamamura, Y | 1 |
2 trial(s) available for mozavaptan and dinoprostone
| Article | Year |
|---|---|
Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Angiotensin II; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Calcium; Creatinine; Dinoprostone; Epinephrine; Heart Rate; Humans; Male; Norepinephrine; Osmolar Concentration; Phosphates; Potassium; Sodium; Thromboxane B2; Uric Acid; Urine; Water; Water Deprivation | 1995 |
Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Dinoprostone; Diuresis; Electrolytes; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration | 1998 |
1 other study(ies) available for mozavaptan and dinoprostone
| Article | Year |
|---|---|
Different cellular mechanisms of vasopressin receptor V1 and V2 subtype in vasopressin-induced adenosine 3', 5'-monophosphate formation in an immortalized renal tubule cell line, TKC2.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Antigens, Polyomavirus Transforming; Benzazepines; Calcium; Cell Line, Transformed; Cyclic AMP; Dinoprostone; Indomethacin; Kidney Tubules; Mice; Mice, Transgenic; Piperidines; Quinolones; Receptors, Vasopressin; Vasopressins | 1994 |